|4May 13, 7:31 PM ET

PLASMATECH BIOPHARMACEUTICALS INC 4

4 · PLASMATECH BIOPHARMACEUTICALS INC · Filed May 13, 2015

Insider Transaction Report

Form 4
Period: 2015-05-11
Jeffrey B Davis
DirectorChief Executive Officer
Transactions
  • Award

    Common stock

    2015-05-11$7.34/sh+300,000$2,202,000300,000 total
  • Award

    Stock option (right to buy)

    2015-05-11$7.34/sh+100,000$734,000140,500 total
    Exercise: $7.34From: 2016-05-11Exp: 2025-05-11Cpmmon stock (100,000 underlying)
Footnotes (2)
  • [F1]300,000 shares of restricted common stock will vest on 5/11/2016.
  • [F2]100% accelerated vesting on change of control.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT